Hemogenyx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 22, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	81	18	34	16	25	57
Market Cap Growth	512.39%	-48.41%	120.18%	-37.12%	-56.46%	512.38%
Enterprise Value	83	19	35	9	13	55
Last Close Price	2.33	1.24	16.00	5.64	11.72	52.00
PB Ratio	-107.69	16.63	9.72	4.00	2.25	47.79
P/TBV Ratio	-	33.78	11.51	4.58	2.37	65.81
Debt / Equity Ratio	-4.03	3.07	1.06	1.06	0.00	1.86
Net Debt / Equity Ratio	-3.62	2.89	0.61	0.27	-0.84	-0.21
Net Debt / EBITDA Ratio	-0.40	-0.48	-0.27	-0.16	2.61	0.09
Net Debt / FCF Ratio	-0.35	-0.59	-0.27	-0.27	2.09	0.09
Quick Ratio	0.43	0.14	1.69	3.40	19.41	1.05
Current Ratio	0.43	0.72	2.93	3.47	20.23	1.08
Return on Equity (ROE)	-631.11%	-309.56%	-222.31%	-69.88%	-112.98%	-795.61%
Return on Assets (ROA)	-70.68%	-65.14%	-61.24%	-44.28%	-30.20%	-72.36%
Return on Capital Employed (ROCE)	-293.10%	-176.10%	-120.50%	-87.20%	-33.10%	-242.80%
Earnings Yield	-13.27%	-39.59%	-24.75%	-30.65%	-27.76%	-4.98%
FCF Yield	-9.50%	-29.26%	-23.02%	-25.72%	-17.77%	-4.71%
Buyback Yield / Dilution	-15.82%	-16.95%	-15.25%	-26.59%	-86.57%	-15.00%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.